The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gruma SAB de CV
OTC:GPAGF
|
MX |
|
P
|
Pacific Metals Co Ltd
DUS:PYV
|
JP |
|
Nippon Ceramic Co Ltd
OTC:NPPRF
|
JP |
|
M
|
MiMedia Holdings Inc
XTSX:MIM
|
CA |
|
Speedy Hire PLC
F:5HN
|
UK |
|
Batliboi Ltd
NSE:BATLIBOI
|
IN |
|
mPay SA
F:8NJ
|
PL |
|
D
|
DeNA Co Ltd
OTC:DNACF
|
JP |
|
A
|
AirBoss of America Corp
F:2S1
|
CA |
|
S
|
Seibu Holdings Inc
SWB:0H9
|
JP |
|
Daesang Holdings Co Ltd
KRX:084690
|
KR |
|
Descartes Systems Group Inc
TSX:DSG
|
CA |
|
Cleantech Vanadium Mining Corp
OTC:CTVFF
|
CA |
|
E
|
ENRG Elements Ltd
OTC:EELFF
|
AU |
|
K
|
Kali Metals Ltd
ASX:KM1
|
AU |
|
H
|
Hana 36 Special Purpose Acquisition Co
KOSDAQ:0101C0
|
KR |
|
Cabaletta Bio Inc
NASDAQ:CABA
|
US |
|
C
|
China High Speed Transmission Equipment Group Co Ltd
SWB:BGR
|
KY |
|
Corbion NV
AEX:CRBN
|
NL |
|
Triad Group PLC
F:TD8
|
UK |
|
E
|
Erbud SA
F:9DP
|
PL |
|
L
|
LBG Media PLC
F:S83
|
UK |
|
Dimerix Ltd
OTC:SBMJF
|
AU |
|
J
|
Jin Yang Pharmaceutical Co Ltd
KOSDAQ:007370
|
KR |
Gruma SAB de CV (GPAGF)’s 12-month stock price forecast through October 2027 has a consensus target of $18.53, implying 41% upside. The forecast is based on price targets from 15 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
GPAGF is 18.53 USD with a low forecast of 13.49 USD and a high forecast of 26.87 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been -15%. The projected CAGR for the next 5 years is 4%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been -13%. The projected CAGR for the next 5 years is 3%.
Over the last 13 years, the compound annual growth rate for Operating Income has been -8%. The projected CAGR for the next 5 years is 2%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -6%. The projected CAGR for the next 3 years is 1%.
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 5 years is 2%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more